Literature DB >> 7281235

Mycobacterium kansasii infection in an endemic area of Czechoslovakia.

M Kubín, E Svandová, B Medek, S Chobot, Z Olsovský.   

Abstract

Over the period 1968-1979, Mycobacterium kansasii was isolated from a total of 297 persons residing in the district of Karviná, North-Moravian Region, Czechoslovakia. Repeated M. kansasii isolations were recorded in 153 patients with clinical symptomatology of chronic respiratory disorders, single isolations in another 144 persons (121 isolations from sputum and/or laryngeal swabs, 22 from urine, and one from the aspirate of a lymph node with tuberculoid granuloma). The incidence of infection with repeated M. kansasii isolation increased from 1.1 to 11.8 per 100 000 population. The ratio of these infections to the number of newly notified cases of pulmonary tuberculosis increased from 3.7 to 33.7%. The average age of patients was 46 years, 84% of all notified cases occurred by 54 years of age and morbidity was highest in the age group 45-54 years and reached 143/100 000 population. The proportion of male patients was 88% and 56% were heavy industry workers occupationally exposed to high dust concentrations.

Entities:  

Mesh:

Year:  1980        PMID: 7281235     DOI: 10.1016/0041-3879(80)90040-9

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  11 in total

1.  Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid.

Authors:  U Hjelm; J Kaustová; M Kubín; S E Hoffner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

2.  Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003.

Authors:  Theodore K Marras; Pamela Chedore; Alicia M Ying; Frances Jamieson
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

3.  Large-restriction-fragment analysis of Mycobacterium kansasii genomic DNA and its application in molecular typing.

Authors:  Y Iinuma; S Ichiyama; Y Hasegawa; K Shimokata; S Kawahara; T Matsushima
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  A case of fatal septicemia due to Mycobacterium kansasii.

Authors:  J Kaustová; A Martínek; R Curík
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

5.  Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics.

Authors:  Theodore K Marras; Mauli Mehta; Pamela Chedore; Kevin May; Mohammed Al Houqani; Frances Jamieson
Journal:  Lung       Date:  2010-04-11       Impact factor: 2.584

6.  Genotypic characterization of five subspecies of Mycobacterium kansasii.

Authors:  M Picardeau; G Prod'Hom; L Raskine; M P LePennec; V Vincent
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

7.  Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007.

Authors:  Mohammed Al Houqani; Frances Jamieson; Pamela Chedore; Mauli Mehta; Kevin May; Theodore K Marras
Journal:  Can Respir J       Date:  2011 Jan-Feb       Impact factor: 2.409

8.  Mycobacterium kansasii pulmonary diseases in Korea.

Authors:  Jae-Joon Yim; Young-Kil Park; Woo Jin Lew; Gill-Han Bai; Sung Koo Han; Young-Soo Shim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

Review 9.  Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.

Authors:  S E Hoffner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

10.  A spatial epidemiological analysis of nontuberculous mycobacterial infections in Queensland, Australia.

Authors:  Michael P Chou; Archie C A Clements; Rachel M Thomson
Journal:  BMC Infect Dis       Date:  2014-05-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.